Skip to main content
. Author manuscript; available in PMC: 2016 Nov 6.
Published in final edited form as: Hepatology. 2013 Oct 1;58(5):1655–1666. doi: 10.1002/hep.26487

Table 3.

Tumor Measurements pre and post Treatment

group A (n=9) (median, range) group B (n=7) (median, range) Total (n=16) (median, range) p-value (Mann-Whitney)
RECIST (mm) baseline 28.7, 13.5-55.9 33.3, 14.9-42.5 29.5, 13.5-55.9 0.68
1 month 26.4, 9.9-45.9 28.4, 13.3-36.9 28.4, 9.9-45.9 0.91
3 months 30.5, 5.6-45.6 27.7, 9.0-63.9 29.1, 5.6-63.9 0.71
WHO (mm) baseline 54.6, 24.4-105.8 57.6, 25.9-76.3 56.8, 24.4-105.8 0.68
1 month 50.5, 19.6-90.2 55.0, 22.2-70.7 53.5, 19.6-90.2 1
3 months 61.0, 10.1-85.0 48.9, 16.5-119.5 55.0, 10.1-119.5 0.71
mRECIST (mm) baseline 28.7, 13.5-55.9 28.8, 14.9-36.9 28.8, 13.5-55.9 1
1 month 9.5, 0.0-25.5 13.0, 0.0-34.3 10.0, 0.0-34.3 0.46
3 months 9.5, 0.0-26.3 0.0, 0.0-63.9 4.8, 0.0-63.9 0.84
EASL (mm) baseline 54.6, 24.4-105.8 56.2, 22.3-72.2 55.4, 22.3-105.8 0.76
1 month 15.1, 0.0-50.5 18.6, 0.0-58.0 16.3, 0.0-58.0 0.40
3 months 16.9, 0.0-47.7 0.0, 0.0-119.5 7.8, 0.0-119.5 0.74
ADC (mm2/s × 10−3) baseline 1.5, 1.2-2.2 1.5, 1.0-1.6 1.5, 1.0-2.2 0.76
1 month 1.5, 0.7-2.9 1.2, 1.1-2.2 1.5, 0.7-2.9 0.69
3 months 1.8, 1.1-2.7 1.3, 1.2-1.5 1.5, 1.1-2.7 0.06